Back
CRISPR Therapeutics AG Vs. Nukkleus Industry Stock Comparison
Sell
28
CRSP
CRISPR Therapeutics AG
Last Price:
$40.74
Seasonality Move:
16.92%
Sell
46
NUKK
Nukkleus
Last Price:
$40.15
Seasonality Move:
-21.57%
Sell
28
CRISPR Therapeutics AG (CRSP)
is a Sell
Is CRISPR Therapeutics AG a Buy, Sell or Hold?
-
The current CRISPR Therapeutics AG [CRSP] share price is $40.72. The Score for CRSP is 28, which is 44% below its historic median score of 50, and infers higher risk than normal.
-
CRSP is currently trading in the 20-30% percentile range relative to its historical Stock Score levels.
-
This Score is currently showing a lower than normal reading, suggesting risk levels may be somewhat higher than normal and additional caution is warranted.
Sell
46
Nukkleus (NUKK)
is a Sell
Is Nukkleus a Buy, Sell or Hold?
-
NUKK is currently trading in the 40-50% percentile range relative to its historical Stock Score levels.
-
This Score is currently showing a lower than normal reading, suggesting risk levels may be somewhat higher than normal and additional caution is warranted.
CRSP Stock Price Chart
What is CRISPR Therapeutics AG's stock price today?
-
The CRISPR Therapeutics AG share price today is $40.72Based on the share price being below its 5, 20 & 50 day exponential moving averages, the current trend is considered strongly bearish and CRSP is experiencing buying pressure, which is a positive indicator for future bullish movement.
NUKK Stock Price Chart
CRSP Technical Analysis
| Chart Indicators | Level | Buy or Sell |
|---|---|---|
| MACD (12, 26): | -2.05 | Sell |
| Relative Strength Index (14 RSI): | 33.92 | Sell |
| Chaikin Money Flow: | 1963017 | - |
| Bollinger Bands | Level | Buy or Sell |
|---|---|---|
| Bollinger Bands (25): | (43.97 - 51.27) | Sell |
| Bollinger Bands (100): | (45.2 - 50.74) | Sell |
NUKK Technical Analysis
| Chart Indicators | Level | Buy or Sell |
|---|---|---|
| MACD (12, 26): | 8.69 | Buy |
| Relative Strength Index (14 RSI): | 77.28 | Buy |
| Chaikin Money Flow: | -1366926 | - |
| Bollinger Bands | Level | Buy or Sell |
|---|---|---|
| Bollinger Bands (25): | (-7.5 - 22.6) | Buy |
| Bollinger Bands (100): | (-4.22 - 11.5) | Buy |
CRSP Moving Averages
| Moving Averages | Level | Buy or Sell |
|---|---|---|
| 8-day SMA: | 43.5 | Sell |
| 20-day SMA: | 47.77 | Sell |
| 50-day SMA: | 48.31 | Sell |
| 200-day SMA: | 53.99 | Sell |
| 8-day EMA: | 43.38 | Sell |
| 20-day EMA: | 46.13 | Sell |
| 50-day EMA: | 47.73 | Sell |
| 200-day EMA: | 52.28 | Sell |
NUKK Moving Averages
| Moving Averages | Level | Buy or Sell |
|---|---|---|
| 8-day SMA: | 20.07 | Buy |
| 20-day SMA: | 9 | Buy |
| 50-day SMA: | 4.99 | Buy |
| 200-day SMA: | 4.78 | Buy |
| 8-day EMA: | 26.51 | Buy |
| 20-day EMA: | 14.21 | Buy |
| 50-day EMA: | 7.47 | Buy |
| 200-day EMA: | 11.77 | Buy |
CRISPR Therapeutics AG Earnings Growth & CRSP Earnings Dates
-
Analysts estimate an earnings decrease this quarter of $0.19 per share, a decrease next quarter of $0.00 per share, a decrease this year of $2.20 per share, and an increase next year of $0.14 per share.
Nukkleus Earnings Growth & NUKK Earnings Dates
-
Analysts estimate an earnings decrease this quarter of $0.00 per share, a decrease next quarter of $0.00 per share, a decrease this year of $0.00 per share, and a decrease next year of $0.00 per share.
CRISPR Therapeutics AG Technical Analysis
| Dec 9 | Dec 10 | Dec 11 | Dec 12 | Dec 13 | Dec 16 | Dec 17 | Dec 18 | Dec 19 | Dec 20 | |
|---|---|---|---|---|---|---|---|---|---|---|
| Dec | ||||||||||
| 09 | 10 | 11 | 12 | 13 | 16 | 17 | 18 | 19 | 20 | |
| Technical Analysis: Buy or Sell? | ||||||||||
| 8-day SMA: | ||||||||||
| 20-day SMA: | ||||||||||
| 50-day SMA: | ||||||||||
| 200-day SMA: | ||||||||||
| 8-day EMA: | ||||||||||
| 20-day EMA: | ||||||||||
| 50-day EMA: | ||||||||||
| 200-day EMA: | ||||||||||
| MACD (12, 26): | ||||||||||
| Relative Strength Index (14 RSI): | ||||||||||
| Bollinger Bands (25): | ||||||||||
| Bollinger Bands (100): | ||||||||||
Nukkleus Technical Analysis
| Dec 9 | Dec 10 | Dec 11 | Dec 12 | Dec 13 | Dec 16 | Dec 17 | Dec 18 | Dec 19 | Dec 20 | |
|---|---|---|---|---|---|---|---|---|---|---|
| Dec | ||||||||||
| 09 | 10 | 11 | 12 | 13 | 16 | 17 | 18 | 19 | 20 | |
| Technical Analysis: Buy or Sell? | ||||||||||
| 8-day SMA: | ||||||||||
| 20-day SMA: | ||||||||||
| 50-day SMA: | ||||||||||
| 200-day SMA: | ||||||||||
| 8-day EMA: | ||||||||||
| 20-day EMA: | ||||||||||
| 50-day EMA: | ||||||||||
| 200-day EMA: | ||||||||||
| MACD (12, 26): | ||||||||||
| Relative Strength Index (14 RSI): | ||||||||||
| Bollinger Bands (25): | ||||||||||
| Bollinger Bands (100): | ||||||||||